Allianz Asset Management
PTCT icon

Allianz Asset Management’s PTC Therapeutics PTCT Stock Holding History

Allianz Asset Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.9M Buy
231,102
+223,702
+3,023% +$16.2M 0.02% 778
2026
Q1 		$504K Sell
7,400
-7,185
-49% -$509K ﹤0.01% 1840
2025
Q4 		$1.11M Buy
14,585
+6,285
+76% +$457K ﹤0.01% 1688
2025
Q3 		$509K Buy
8,300
+700
+9% +$36.5K ﹤0.01% 1837
2025
Q2 		$371K Sell
7,600
-5,300
-41% -$252K ﹤0.01% 1881
2025
Q1 		$657K Sell
12,900
-4,700
-27% -$235K ﹤0.01% 1792
2024
Q4 		$794K Buy
+17,600
New +$753K ﹤0.01% 1715
2022
Q3 		– Sell
-18,495
Closed -$741K – 2074
2022
Q2 		$741K Sell
18,495
-53,180
-74% -$1.86M ﹤0.01% 1778
2022
Q1 		$2.67M Hold
71,675
– – ﹤0.01% 1483
2021
Q4 		$2.86M Buy
+71,675
New +$2.74M ﹤0.01% 1470
2021
Q2 		– Sell
-22,800
Closed -$1.08M – 2463
2021
Q1 		$1.08M Sell
22,800
-61
-0.3% -$3.62K ﹤0.01% 1613
2020
Q4 		$1.4M Sell
22,861
-492
-2% -$29K ﹤0.01% 1405
2020
Q3 		$1.09M Sell
23,353
-25,889
-53% -$1.27M ﹤0.01% 1408
2020
Q2 		$2.5M Sell
49,242
-27,660
-36% -$1.36M ﹤0.01% 1520
2020
Q1 		$3.43M Sell
76,902
-64,328
-46% -$3.24M ﹤0.01% 1323
2019
Q4 		$6.78M Buy
141,230
+768
+0.5% +$32.6K 0.01% 1341
2019
Q3 		$4.77M Buy
140,462
+48,340
+52% +$2.1M ﹤0.01% 1469
2019
Q2 		$4.15M Buy
92,122
+56,008
+155% +$2.21M ﹤0.01% 1588
2019
Q1 		$1.36M Sell
36,114
-42,234
-54% -$1.42M ﹤0.01% 1977
2018
Q4 		$2.66M Buy
78,348
+24,763
+46% +$890K ﹤0.01% 1651
2018
Q3 		$2.52M Sell
53,585
-2,000
-4% -$82.8K ﹤0.01% 1856
2018
Q2 		$1.88M Buy
55,585
+30,285
+120% +$944K ﹤0.01% 1973
2018
Q1 		$685K Buy
+25,300
New +$641K ﹤0.01% 2313

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Allianz Asset Management's PTCT Position: Q2 2026 in Review

Allianz Asset Management increased its PTC Therapeutics (PTCT) stake by 3,023% in Q2 2026, buying an estimated $16.2M and bringing the position to 231,102 shares worth $18.9M. The position accounts for 0.02% of the portfolio, ranked #778.

Allianz Asset Management first reported a position in PTCT in Q1 2018 and has held it in 23 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Allianz Asset Management held 231,102 shares of PTC Therapeutics worth $18.9M as of Q2 2026.
  • Allianz Asset Management bought 223,702 PTC Therapeutics shares in Q2 2026, an estimated $16.2M.
  • PTC Therapeutics made up 0.02% of Allianz Asset Management's portfolio in Q2 2026, its #778 holding.
  • Allianz Asset Management first reported a position in PTC Therapeutics in Q1 2018 and has held it in 23 quarters since.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Allianz Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.